SCHEDULE: Vanguard Capital Management Corrects Pediatrix Filing

Vanguard Capital Management has filed a Schedule 13G amendment to correct a previously reported CIK number for Pediatrix Medical Group, Inc., confirming no change in beneficial ownership.

Summary

• Vanguard Capital Management filed a Schedule 13G to correct the CIK number for Pediatrix Medical Group, Inc.
• The filing date for the event requiring this statement is March 31, 2026.
• Vanguard Capital Management reports beneficial ownership of 4,283,221 shares of Pediatrix Medical Group, Inc. common stock.
• This represents 5.15% of the class of securities.
• The filing clarifies that this is a correction and no change in beneficial ownership is being reported.
• Vanguard Capital Management has sole voting power over 626,900 shares and sole dispositive power over 4,283,221 shares.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily a correction of a previous filing without new ownership information.

Positives

• Correction of filing errors demonstrates diligence in regulatory compliance.
• Confirmation of existing ownership levels indicates no unexpected divestment or acquisition by a major holder.

Negatives

• The need for a correction implies a procedural oversight in the initial filing.

Risks

• Potential for minor confusion or misinterpretation due to the filing correction, though unlikely to be significant.

Future Outlook

No forward-looking statements or guidance are present in this filing, as it is a correction of a previous ownership report.

Management Comments

• In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd.
• This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power.
• This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.
• This submission is being filed solely to correct the issuer CIK reported in a previously filed Schedule 13G. No change in beneficial ownership is being reported.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard for institutional investors exceeding a 5% ownership threshold. This particular filing is a procedural correction, indicating routine portfolio management by Vanguard rather than a strategic shift concerning Pediatrix Medical Group.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a correction of a prior filing and does not reflect a change in beneficial ownership. It reinforces the stability of Vanguard's holding.
• Regulators: Ensures accurate reporting of ownership stakes, maintaining transparency in the market.

Next Steps

• Continue to monitor future filings from Vanguard Capital Management for any changes in beneficial ownership of Pediatrix Medical Group, Inc.

Key Dates

Keywords

Pediatrix Medical Group, Vanguard Capital Management, Schedule 13G, Beneficial Ownership, Stock Ownership, SEC Filing, Ownership Correction